Of note, renal cell carcinoma is a highly immunogenic entity: Harter et al. demonstrated that they had the highest levels of CD3+ and CD8+ lymphocytes and the strongest PD-1 levels, which correlates to smaller brain tumor sizes [144]. This evidence concerns the gene CD8A and brain neoplasm.